Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.
about
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopeniaRhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Immune thrombocytopeniaContemporary management of primary immune thrombocytopenia in adultsPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaNumerical analysis of in vivo platelet consumption data from ITP patientsPredictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura.Major histocompatibility complex susceptibility genes and immune thrombocytopenic purpura in Caucasian adults.Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment.Adult idiopathic thrombocytopenic purpura.Postsplenectomy recurrence of thrombocytopenia with an accessory spleenHaematopoietic stem and progenitor cell-targeted therapies for thrombocytopenia.Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.New insights and therapeutics for immune-mediated thrombocytopenia.Pathobiology of secondary immune thrombocytopenia.The ITP syndrome: pathogenic and clinical diversity.Treatment of immune thrombocytopenic purpura: focus on eltrombopag.Thrombopoietin and platelet production in chronic immune thrombocytopenia.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseManagement of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleNovel clearance mechanisms of platelets.Current status of thrombopoietic agents.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients.ITP: a historical perspective.Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia.Immune thrombocytopenia: no longer 'idiopathic'.Increased number of B-cells in the red pulp of the spleen in ITP.Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets.Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.Romiplostim dose response in patients with immune thrombocytopenia.Successful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
P2860
Q26745753-B8A79206-85DA-47AF-BF3A-5A434FAEB97FQ26824798-629EDA2B-12F6-4E19-BC56-CC278F898B40Q26830918-83C50F6E-0C12-4C0B-836A-A814A56EF12EQ26853680-9FEFFDF4-DBDB-42E6-A93B-074471977A32Q27024841-008E67DC-DB35-4F72-A786-F900F23FCF93Q31010919-665BD5FB-1B15-449C-8110-FCD19ADB2209Q33337316-A9F3FA2C-051C-42B1-9FCF-7D956AA7EB9BQ33341065-3FB5E97D-7B81-4971-B4E6-3046DB0042ACQ33343830-008C27B5-7710-43D5-9BAA-E1011CA9A307Q33343948-960343E5-DD91-45AA-8715-6AB3E6F61E53Q33344045-91F6212E-6078-4A8B-A46C-65C5F7A9A7E9Q33349710-C22292BB-0ABC-4A42-A299-0F12C06ACBF8Q33358032-F9D38C87-CCD4-4E56-948B-6BEBE0D2F778Q33363217-5D864FEE-4027-4748-B2A2-771F125B6385Q33372720-2B0CD79B-9558-4872-A098-7983A4D6AFA2Q33372724-A0B1E69E-14C1-4CAF-B8D7-E887C9A620A5Q33377901-4C7539EF-A562-4B2B-A378-EADDDBB4E253Q33383468-5A7AD8F2-AC06-44E1-AFA4-7535031EC898Q33384235-40782BE7-81AD-4E44-AAB0-744149C1771AQ33385976-C74166C6-5180-4086-946C-6EFFE94ADF7FQ33387153-1D991D55-8F1A-41CA-B935-5EF5366DEDBEQ33387735-A594D39E-F7A0-451B-ADEA-A96853109CC2Q33388213-CC921465-16C3-47AD-8786-AC4B8693134EQ33390001-4651FD5A-A1C5-4E69-8B86-F495C2F23A6EQ33391541-FCC9B15D-FBCB-47A9-8D78-C841AFD697DBQ33392858-8DF1C53A-A085-46B3-A49F-C5302A03BDD2Q33392868-E82C1EB4-D7A2-420A-9149-A1A492BE301EQ33393732-3CFF626D-FACB-424D-9939-8DFA7D9F7F49Q33394438-B6B04182-0801-4BB0-B908-7EC7807BC089Q33394781-D530060A-0911-45D9-B053-EC6D88570114Q33394791-39994390-A1D4-40E6-9404-D2B66AB52E11Q33395130-8CE65FD9-1450-40C3-854B-5E725606EC52Q33395519-F345E873-384D-4D62-B78D-552872933AEAQ33395624-C2DC1EF4-7921-47FB-9A46-53E145223A94Q33396338-81178CF4-94E2-4349-8901-01E6C24E9900Q33397149-7D345D8B-F526-4C3D-BC23-947153659528Q33398568-8514657E-0845-43B8-8039-AEFF4046A4CCQ33398730-6873FC57-3E67-48BC-88E9-0CEF42F036C9Q33399821-435B91E9-BE9F-4C75-964A-23956C84D4EBQ33400018-F281DF57-4812-4E45-9893-ABDF992AB788
P2860
Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@ast
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@en
type
label
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@ast
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@en
prefLabel
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@ast
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@en
P2093
P2860
P356
P1476
Mechanisms of thrombocytopenia ...... increased platelet clearance.
@en
P2093
J R Stratton
J W Adamson
P J Ballem
S J Slichter
T Gernsheimer
P2860
P356
10.1172/JCI113060
P407
P577
1987-07-01T00:00:00Z